Nextech Invest Ag Theseus Pharmaceuticals, Inc. Transaction History

Nextech Invest Ag

  • $535 Million
  • Q1 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
BUY
$8.98 - $20.09 $5.49 Million - $12.3 Million
611,310 New
611,310 $7.75 Million

Others Institutions Holding THRX

# of Institutions
3
Shares Held
1.06M
Call Options Held
0
Put Options Held
0
View Full List

About Theseus Pharmaceuticals, Inc.

THRX Quotes by TradingView
  • Ticker THRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,713,400
  • Description
  • Theseus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of targeted therapies for the treatment of cancer patients. Its lead product candidate is THE-630, a pan-KIT inhibitor for the treatment of gastrointestinal stromal tumors, which is in Phase I clinical trial. The company also ...
More about THRX
Track This Portfolio

Track Nextech Invest Ag Portfolio

Follow Nextech Invest Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nextech Invest Ag, based on Form 13F filings with the SEC.

News

Stay updated on Nextech Invest Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email